Cut-off Values of Muscle Thickness Ratio for Sarcopenia
NCT ID: NCT03993405
Last Updated: 2019-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
292 participants
INTERVENTIONAL
2019-01-01
2019-08-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sternocleidomastoid Thickness in Sarcopenia
NCT05928845
Diagnostic Evaluation of Sarcopenia in Elderly Patients
NCT04451005
Evaluation of Sarcopenia in Elderly at the Emergency Department
NCT05567549
Assessment of the Prognostic Value of the Thickness of the Quadriceps and Abdominal Muscles Measured by Ultrasound for 28-day Mortality in Postoperative ICU Patients
NCT05276921
Muscle Assessment Through Ultrasound in the Evaluation of Acute Sarcopenia
NCT03740061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, ultrasound measurements has a high sensitivity and specify for confirming the diagnosis of sarcopenia. However there is no information about cut-off values in this respect in the literature. Therefore, the aim of this study is to determine the cut-off values of this ratio for confirming the diagnosis of sarcopenia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group:young
Sixty older subjects will be evaluated in this study.
Ultrasonographic evaluation
Ultrasonographic measurement is assessment method to diagnosis of sarcopenia
Control Group:Middle-aged
Sixty middle-aged subjects will be evaluated in this study.
Ultrasonographic evaluation
Ultrasonographic measurement is assessment method to diagnosis of sarcopenia
Experimental group:older
Sixty older subjects will be evaluated in this study.
Ultrasonographic evaluation
Ultrasonographic measurement is assessment method to diagnosis of sarcopenia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasonographic evaluation
Ultrasonographic measurement is assessment method to diagnosis of sarcopenia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To be an aged 18-90 years old.
Exclusion Criteria
* Having a visual deficits
* Having an undergone orthopedic surgery
* Having a cardiac pacemaker
* Having a hypothyroidism, diabetes mellitus, renal/hepatic failure
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ozden Ozkal
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ozden Ozkal
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GO 18/506-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.